- Home
- ACHV vs RDCM Comparison
ACHV vs RDCM Comparison
Compare ACHV & RDCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- RDCM
- Stock Information
- Founded
- ACHV N/A
- RDCM 1985
- Country
- ACHV Canada
- RDCM Israel
- Employees
- ACHV N/A
- RDCM N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- RDCM Computer peripheral equipment
- Sector
- ACHV Health Care
- RDCM Technology
- Exchange
- ACHV Nasdaq
- RDCM Nasdaq
- Market Cap
- ACHV 149.6M
- RDCM 157.9M
- IPO Year
- ACHV N/A
- RDCM 1997
- Fundamental
- Price
- ACHV $4.33
- RDCM $11.71
- Analyst Decision
- ACHV Strong Buy
- RDCM Strong Buy
- Analyst Count
- ACHV 5
- RDCM 1
- Target Price
- ACHV $14.80
- RDCM $14.00
- AVG Volume (30 Days)
- ACHV 116.0K
- RDCM 74.2K
- Earning Date
- ACHV 11-07-2024
- RDCM 11-13-2024
- Dividend Yield
- ACHV N/A
- RDCM N/A
- EPS Growth
- ACHV N/A
- RDCM 660.55
- EPS
- ACHV N/A
- RDCM 0.46
- Revenue
- ACHV N/A
- RDCM $58,755,000.00
- Revenue This Year
- ACHV N/A
- RDCM $17.18
- Revenue Next Year
- ACHV N/A
- RDCM $11.32
- P/E Ratio
- ACHV N/A
- RDCM $24.22
- Revenue Growth
- ACHV N/A
- RDCM 17.80
- 52 Week Low
- ACHV $3.03
- RDCM $7.70
- 52 Week High
- ACHV $5.98
- RDCM $12.44
- Technical
- Relative Strength Index (RSI)
- ACHV 40.62
- RDCM 59.92
- Support Level
- ACHV $4.12
- RDCM $11.16
- Resistance Level
- ACHV $4.46
- RDCM $11.91
- Average True Range (ATR)
- ACHV 0.24
- RDCM 0.54
- MACD
- ACHV -0.05
- RDCM 0.08
- Stochastic Oscillator
- ACHV 17.65
- RDCM 67.26
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About RDCM Radcom Ltd.
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.